found increased expression of PD-L1 in glioblastoma tumor-infiltrating myeloid cells, and greater efficiency of a DCV was achieved in a preclinical murine glioblastoma model when combined with a PD-1 blocking monoclonal antibody (135, 136). The gene discussed is PDCD1; the disease is glioblastoma.